List of works - Karita Peltonen

A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.

scientific article published on January 2014

Artificially cloaked viral nanovaccine for cancer immunotherapy

scientific article published on 17 December 2019

Contrasting DNA damage checkpoint responses in epithelium of the human seminal vesicle and prostate.

scientific article published on 9 November 2011

Design, synthesis, and structure-activity relationships of pyridoquinazolinecarboxamides as RNA polymerase I inhibitors

scientific article

Exploiting pre-existing immunity to enhance oncolytic cancer immunotherapy

scientific article published on 27 February 2020

Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy

scientific article published on 23 October 2019

Human prostate epithelium lacks Wee1A-mediated DNA damage-induced checkpoint enforcement

scholarly article

Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agents

scientific article

KIT overexpression induces proliferation in astrocytes in an imatinib-responsive manner and associates with proliferation index in gliomas.

scientific article published in August 2008

Melanoma cell lines are susceptible to histone deacetylase inhibitor TSA provoked cell cycle arrest and apoptosis.

scientific article

Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation

scientific article

Oncogenic Herpesvirus Utilizes Stress-Induced Cell Cycle Checkpoints for Efficient Lytic Replication

scientific article published on 18 February 2016

Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

scientific article published on 07 May 2018

Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

scholarly article by Erkko Ylösmäki published in September 2018

Proteasome activity influences UV-mediated subnuclear localization changes of NPM.

scientific article

Severe neurodegenerative disease in brothers with homozygous mutation in POLR1A.

scientific article published on 4 January 2017

Small molecule BMH-compounds that inhibit RNA polymerase I and cause nucleolar stress.

scientific article

Small-Molecule Targeting of RNA Polymerase I Activates a Conserved Transcription Elongation Checkpoint.

scientific article published in April 2018

List of works by Karita Peltonen

A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.

Artificially cloaked viral nanovaccine for cancer immunotherapy

Contrasting DNA damage checkpoint responses in epithelium of the human seminal vesicle and prostate.

Design, synthesis, and structure-activity relationships of pyridoquinazolinecarboxamides as RNA polymerase I inhibitors

Exploiting pre-existing immunity to enhance oncolytic cancer immunotherapy

Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy

Human prostate epithelium lacks Wee1A-mediated DNA damage-induced checkpoint enforcement

Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agents

KIT overexpression induces proliferation in astrocytes in an imatinib-responsive manner and associates with proliferation index in gliomas.

Melanoma cell lines are susceptible to histone deacetylase inhibitor TSA provoked cell cycle arrest and apoptosis.

Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation

Oncogenic Herpesvirus Utilizes Stress-Induced Cell Cycle Checkpoints for Efficient Lytic Replication

Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

Proteasome activity influences UV-mediated subnuclear localization changes of NPM.

Severe neurodegenerative disease in brothers with homozygous mutation in POLR1A.

Small molecule BMH-compounds that inhibit RNA polymerase I and cause nucleolar stress.

Small-Molecule Targeting of RNA Polymerase I Activates a Conserved Transcription Elongation Checkpoint.